Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: A randomized controlled trial

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 8, 2010, Pages 1167-1172

  Sinha, Rajesh ^a   Jhanji, Vishal ^b,c   Verma, Kamna ^a   Sharma, Namrata ^a   Biswas, Nihar R ^a   Vajpayee, Rasik B ^a,b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Corneal graft rejection; Cyclosporine; High risk keratoplasty; Keratoplasty

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; METHYLPREDNISOLONE; PLACEBO; POLYVINYL ALCOHOL; PREDNISOLONE ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EROSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EYE IRRITATION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT INDICATION; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77955550035     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1388-8     Document Type: Article

References (20)

1. Williams KA, Lowe MT, Bartlett CM, Kelly L, Coster DJ (2007) The Australian Corneal Graft Registry 2007 Report. Flinders University Press, Adelaide
2. RA Wolfe 2004 Long-term renal allograft survival: a cup half-full and half-empty Am J Transplant; 4 1215 1216 10.1111/j.1600-6143.2004.00567.x 15268720 (Pubitemid 39013565)
3. SE Wilson HE Kaufman 1990 Graft failure after penetrating keratoplasty Surv Ophthalmol; 34 325 356 10.1016/0039-6257(90)90110-H 1:STN:280: DyaK3c3itlahuw%3D%3D 2183380 (Pubitemid 20105482)
4. The Collaborative Corneal Transplantation Research Group. The collaborative corneal transplantation studies (CCTS) 1992 Effectiveness of histocompatibility matching in high risk corneal transplantation Arch Ophthalmol 110 1392 1403
5. Khodadaust AA (1973) The allograft rejection reaction: the leading cause of late graft failure of clinical corneal grafts. In: Porter R, Knight J (eds) Corneal graft failure. Ciba Foundation Symposium 15. Elsevier, Amsterdam, pp 151-164
6. KR Barba A Samy C Lai JI Perlman CS Bouchard 2000 Effect of topical anti-inflammatory drugs on corneal and limbal wound healing J Cataract Refract Surg 26 893 897 10.1016/S0886-3350(00)00364-3 1:STN:280:DC%2BD3cvivFKltA%3D%3D 10889437 (Pubitemid 30482631)
7. Leibowitz H (1979) Ocular toxicity of corticosteroids. In: Leopold IH, Burns RP (eds) Symposium on ocular therapy, vol. 11, Wiley, New York, pp 108-109
8. MF Armaly 1963 Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye Arch Ophthalmol 70 482 491 1:STN:280:DyaF2c%2Fjs1Gisw%3D%3D 14078870
9. JM Lewis T Priddy J Judd MO Gordon MA Kass AE Kolker Becker 1988 Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma Am J Ophthalmol 106 607 612 10.1016/0002-9394(88)90595-8 1:STN:280:DyaL1M%2FkslKksA%3D%3D 3189477 (Pubitemid 18260819)
10. B Becker 1965 Intraocular pressure response to topical corticosteroids Invest Ophthalmol 4 198 205 1:STN:280:DyaF2M%2FoslGrtw%3D%3D 14283013
11. MW Belin CS Bouchard TM Phillips 1990 Update on topical cyclosporine A. Background, immunology, and pharmacology Cornea 9 184 195 10.1097/00003226- 199007000-00002 1:STN:280:DyaK3czit1Ortw%3D%3D 2197063
12. JC Hill 1995 Systemic cyclosporine in high-risk keratoplasty: long-term results Eye 9 422 428 7498559
13. AC Poon JE Forbes JK Dart S Subramaniam C Bunce P Madison LA Ficker SJ Tuft DS Gartry RJ Buckley 2001 Systemic cyclosporine A in high-risk penetrating keratoplasties: a case-control study Br J Ophthalmol 85 1464 1469 10.1136/bjo.85.12.1464 1:STN:280:DC%2BD3MnovVSltA%3D%3D 11734522 (Pubitemid 34032915)
14. R Tandon B Chawla K Verma N Sharma JS Titiyal 2008 Outcome of treatment of Mooren ulcer with topical cyclosporine A 2% Cornea 27 859 861 10.1097/ICO.0b013e3181702d0c 18724142
15. JC Zhao XY Jin 1995 Local therapy of corneal allograft rejection with cyclosporine Am J Ophthalmol 119 189 194 1:STN:280:DyaK2M7jtlKhsw%3D%3D 7832225
16. CB Cosar PR Laibson EJ Cohen CJ Rapuano 2003 Topical cyclosporine in pediatric keratoplasty Eye Contact Lens 29 103 107 10.1097/01.ICL.0000062460. 03555.32 12695714 (Pubitemid 43189078)
17. M Wiederholt D Kossendrup W Schulz F Hoffmann 1986 Pharmacokinetic of topical cyclosporine A in the rabbit eye Invest Ophthalmol Vis Sci 27 519 524 1:CAS:528:DyaL28XitFymurc%3D 3957569
18. K Inoue S Amano C Kimura T Sato N Fujita F Kagaya Y Kaji T Oshika T Tsuru M Araie 2000 Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty Jpn J Ophthalmol 44 302 305 10.1016/S0021-5155(99) 00223-3 1:CAS:528:DC%2BD3cXksFGhsr4%3D 10913651 (Pubitemid 30417522)
19. MO Price FW Price 2006 Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episode Ophthalmology 113 1785 1790 10.1016/j.ophtha.2006.05.022 16884779 (Pubitemid 44442441)
20. A Poon M Constantinou E Lamoureux HR Taylor 2008 Topical cyclosporine A in the treatment of acute graft rejection: a randomized controlled trial Clin Experiment Ophthalmol 36 415 421 18939344